151 - 200 of 9038 Results
Title
Year
-
RESTRICTEDTitle: Ten Unsolved Questions About Neuroinflammation in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 1Start Page: 16End Page: 24Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28075Best OA location URL: https://inserm.hal.science/inserm-02568209/file/ReviewMDSinflammationRev11%20dgs%20eh.pdfCitation Count: 142
-
RESTRICTEDTitle: Linking neuroscience with modern concepts of impulse control disorders in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 2Start Page: 141End Page: 149Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26068Best OA location URL: https://europepmc.org/articles/pmc4318759?pdf=renderCitation Count: 79
-
RESTRICTEDTitle: Vascular Parkinsonism: Deconstructing a SyndromeJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 7Start Page: 886End Page: 894Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26263Best OA location URL: https://europepmc.org/articles/pmc4478160?pdf=renderCitation Count: 87
-
RESTRICTEDTitle: LRRK2 inhibitors and their potential in the treatment of Parkinson’s disease: current perspectivesJournal Name: Clinical Pharmacology: Advances and ApplicationsPublisher: Informa UK LimitedVol: Volume 8Issue #:Start Page: 177End Page: 189Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.2147/cpaa.s102191Best OA location URL: https://www.dovepress.com/getfile.php?fileID=33080Citation Count: 41
-
RESTRICTEDTitle: Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairmentJournal Name: Human Brain MappingPublisher: WileyVol: 40Issue #: 18Start Page: 5424End Page: 5442Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/hbm.24782Best OA location URL: https://europepmc.org/articles/pmc6864887?pdf=renderCitation Count: 130
-
RESTRICTEDTitle: LRRK2 mutations and neurotoxicant susceptibilityJournal Name: Experimental Biology and MedicinePublisher: Frontiers Media SAVol: 240Issue #: 6Start Page: 752End Page: 759Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1177/1535370215579162Best OA location URL: https://europepmc.org/articles/pmc4935210?pdf=renderCitation Count: 28
-
RESTRICTEDTitle: At the dawn of the transcriptomic medicineJournal Name: Experimental Biology and MedicinePublisher: Frontiers Media SAVol: 246Issue #: 3Start Page: 286End Page: 292Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1177/1535370220954788Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876640Citation Count: 7
-
RESTRICTEDTitle: Transcriptional mutagenesis by 8-oxodG in α-synuclein aggregation and the pathogenesis of Parkinson’s diseaseJournal Name: Experimental & Molecular MedicinePublisher: Springer Science and Business Media LLCVol: 47Issue #: 8Start Page: e179End Page: e179Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/emm.2015.54Best OA location URL: https://www.nature.com/articles/emm201554.pdfCitation Count: 27
-
RESTRICTEDTitle: Mitochondrial isolation: when size mattersJournal Name: Wellcome Open ResearchPublisher: F1000 Research LtdVol: 5Issue #:Start Page: 226End Page: 226Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.12688/wellcomeopenres.16300.2Best OA location URL: https://wellcomeopenresearch.org/articles/5-226/v2/pdfCitation Count: 4
- Recent Advances in the Development of Stem‐Cell‐Derived Dopaminergic Neuronal Transplant Therapies for Parkinson's Disease2021RESTRICTEDTitle: Recent Advances in the Development of Stem‐Cell‐Derived Dopaminergic Neuronal Transplant Therapies for Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1772End Page: 1780Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28628Citation Count: 34
-
RESTRICTEDTitle: How to proceed after “negative” exome: A review on genetic diagnostics, limitations, challenges, and emerging new multiomics techniquesJournal Name: Journal of Inherited Metabolic DiseasePublisher: WileyVol: 45Issue #: 4Start Page: 663End Page: 681Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/jimd.12507Best OA location URL: https://repository.ubn.ru.nl/bitstream/handle/2066/282561/1/282561.pdfCitation Count: 20
-
RESTRICTEDTitle: GALC variants affect galactosylceramidase enzymatic activity and risk of Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 146Issue #: 5Start Page: 1859End Page: 1872Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awac413Best OA location URL: https://academic.oup.com/brain/article-pdf/146/5/1859/50127735/awac413.pdfCitation Count: 11
-
RESTRICTEDTitle: Risk of Chronic Cardiomyopathy Among Patients With the Acute Phase or Indeterminate Form of Chagas DiseaseJournal Name: JAMA Network OpenPublisher: American Medical Association (AMA)Vol: 3Issue #: 8Start Page: e2015072End Page: e2015072Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1001/jamanetworkopen.2020.15072Best OA location URL: https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2770045/chadalawada_2020_oi_200567_1602703565.56257.pdfCitation Count: 50
-
RESTRICTEDTitle: LRRK2 Phosphorylation, More Than an EpiphenomenonJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2020.00527Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2020.00527/pdfCitation Count: 41
-
RESTRICTEDTitle: Clinical implications of gastric complications on levodopa treatment in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 76Issue #:Start Page: 63End Page: 71Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.05.001Best OA location URL: http://www.prd-journal.com/article/S1353802020301103/pdfCitation Count: 42
-
RESTRICTEDTitle: Excitotoxicity Revisited: Mitochondria on the Verge of a Nervous BreakdownJournal Name: Trends in NeurosciencesPublisher: Elsevier BVVol: 44Issue #: 5Start Page: 342End Page: 351Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.tins.2021.01.001Best OA location URL: https://discovery.ucl.ac.uk/10122786/9/Duchen_071220_Plotegher%20et%20al._final.pdfCitation Count: 28
-
RESTRICTEDTitle: The Evolution-Driven Signature of Parkinson’s DiseaseJournal Name: Trends in NeurosciencesPublisher: Elsevier BVVol: 43Issue #: 7Start Page: 475End Page: 492Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.tins.2020.05.001Best OA location URL: https://doi.org/10.1016/j.tins.2020.05.001Citation Count: 23
-
RESTRICTEDTitle: Multidisciplinary Care to Optimize Functional Mobility in Parkinson DiseaseJournal Name: Clinics in Geriatric MedicinePublisher: Elsevier BVVol: 36Issue #: 1Start Page: 159End Page: 172Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.cger.2019.09.008Best OA location URL: https://repository.ubn.ru.nl//bitstream/handle/2066/214080/214080.pdfCitation Count: 19
- BRAF V600E mutation and MET amplification as resistance pathways of the second-generation anaplastic lymphoma kinase (ALK) inhibitor alectinib in lung cancer2020RESTRICTEDTitle: BRAF V600E mutation and MET amplification as resistance pathways of the second-generation anaplastic lymphoma kinase (ALK) inhibitor alectinib in lung cancerJournal Name: Lung CancerPublisher: Elsevier BVVol: 146Issue #:Start Page: 78End Page: 85Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.lungcan.2020.05.018Citation Count: 25
-
RESTRICTEDTitle: Disruptions of neurological services, its causes and mitigation strategies during COVID-19: a global reviewJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 268Issue #: 11Start Page: 3947End Page: 3960Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-021-10588-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-021-10588-5.pdfCitation Count: 28
- Drug Repurposing: Considerations to Surpass While Re-directing Old Compounds for New Treatments2021RESTRICTEDTitle: Drug Repurposing: Considerations to Surpass While Re-directing Old Compounds for New TreatmentsJournal Name: Archives of Medical ResearchPublisher: Elsevier BVVol: 52Issue #: 3Start Page: 243End Page: 251Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.arcmed.2020.10.021Citation Count: 25
- Measuring the Impact of Patient Engagement and Patient Centricity in Clinical Research and Development2020RESTRICTEDTitle: Measuring the Impact of Patient Engagement and Patient Centricity in Clinical Research and DevelopmentJournal Name: Therapeutic Innovation & Regulatory SciencePublisher: Springer Science and Business Media LLCVol: 54Issue #: 1Start Page: 103End Page: 116Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s43441-019-00034-0Citation Count: 27
-
RESTRICTEDTitle: Progress in the molecular pathogenesis and nucleic acid therapeutics for Parkinson's disease in the precision medicine eraJournal Name: Medicinal Research ReviewsPublisher: WileyVol: 40Issue #: 6Start Page: 2650End Page: 2681Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/med.21718Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/med.21718Citation Count: 33
-
RESTRICTEDTitle: Upstream deregulation of calcium signaling in Parkinson’s diseaseJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 7Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2014.00053Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2014.00053/pdfCitation Count: 20
-
RESTRICTEDTitle: Parkinson’s disease-implicated kinases in the brain; insights into disease pathogenesisJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 7Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2014.00057Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2014.00057/pdfCitation Count: 67
-
RESTRICTEDTitle: Targeting Alpha-Synuclein as a Therapy for Parkinson’s DiseaseJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2019.00299Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2019.00299/pdfCitation Count: 217
-
RESTRICTEDTitle: New Developments in Genetic rat models of Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 5Start Page: 717End Page: 729Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27296Best OA location URL: https://europepmc.org/articles/pmc5992003?pdf=renderCitation Count: 70
-
RESTRICTEDTitle: CNS-Derived Blood Exosomes as a Promising Source of Biomarkers: Opportunities and ChallengesJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2020.00038Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2020.00038/pdfCitation Count: 154
-
RESTRICTEDTitle: Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathiesJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 3Start Page: 372End Page: 390Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27344Best OA location URL: https://europepmc.org/articles/pmc5844369?pdf=renderCitation Count: 162
-
RESTRICTEDTitle: From reinforcement learning models to psychiatric and neurological disordersJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 14Issue #: 2Start Page: 154End Page: 162Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/nn.2723Best OA location URL: https://europepmc.org/articles/pmc4408000?pdf=renderCitation Count: 648
-
RESTRICTEDTitle: Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?Journal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 7Start Page: 955End Page: 971Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27038Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27038Citation Count: 179
-
RESTRICTEDTitle: Which ante mortem clinical features predict progressive supranuclear palsy pathology?Journal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 7Start Page: 995End Page: 1005Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27034Best OA location URL: https://europepmc.org/articles/pmc5543934?pdf=renderCitation Count: 127
-
RESTRICTEDTitle: Neuropathology of genetic synucleinopathies with parkinsonism: Review of the literatureJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 11Start Page: 1504End Page: 1523Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27193Best OA location URL: https://europepmc.org/articles/pmc5726430?pdf=renderCitation Count: 237
-
RESTRICTEDTitle: Essential pitfalls in “essential” tremorJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 3Start Page: 325End Page: 331Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26919Best OA location URL: https://europepmc.org/articles/pmc5359065?pdf=renderCitation Count: 77
-
RESTRICTEDTitle: Initial cognitive changes in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 4Start Page: 511End Page: 519Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27330Best OA location URL: https://europepmc.org/articles/pmc5920539?pdf=renderCitation Count: 44
- Targeting the pedunculopontine nucleus in Parkinson's disease: Time to go back to the drawing board2018RESTRICTEDTitle: Targeting the pedunculopontine nucleus in Parkinson's disease: Time to go back to the drawing boardJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 12Start Page: 1871End Page: 1875Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27540Best OA location URL: http://deepblue.lib.umich.edu/bitstream/2027.42/147041/2/mds27540_am.pdfCitation Count: 19
-
RESTRICTEDTitle: Gene Therapy Strategies to Restore ER Proteostasis in DiseaseJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 26Issue #: 6Start Page: 1404End Page: 1413Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ymthe.2018.04.004Best OA location URL: https://doi.org/10.1016/j.ymthe.2018.04.004Citation Count: 35
-
RESTRICTEDTitle: Parkinson's Disease Biomarkers: Where Are We and Where Do We Go Next?Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 4Issue #: 6Start Page: 796End Page: 805Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12545Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12545Citation Count: 18
-
RESTRICTEDTitle: Diagnosis and treatment of orthostatic hypotensionJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 8Start Page: 735End Page: 746Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(22)00169-7Best OA location URL: https://pure.rug.nl/ws/files/234637992/1_s2.0_S1474442222001697_main.pdfCitation Count: 54
-
RESTRICTEDTitle: Ansätze zur Etablierung von Präzisionsmedizin bei der Parkinson-Krankheit mit dem Schwerpunkt GenetikJournal Name: Fortschritte der Neurologie · PsychiatriePublisher: Georg Thieme Verlag KGVol: 88Issue #: 09Start Page: 558End Page: 566Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1055/a-1149-2204Best OA location URL: http://www.thieme-connect.de/products/ejournals/pdf/10.1055/a-1149-2204.pdfCitation Count: 0
-
RESTRICTEDTitle: The economic imperatives for technology enabled wellness centered healthcareJournal Name: Journal of Public Health PolicyPublisher: Springer Science and Business Media LLCVol: 43Issue #: 3Start Page: 456End Page: 468Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1057/s41271-022-00356-8Best OA location URL: https://link.springer.com/content/pdf/10.1057/s41271-022-00356-8.pdfCitation Count: 2
-
RESTRICTEDTitle: Alzheimer’s disease large-scale gene expression portrait identifies exercise as the top theoretical treatmentJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-022-22179-zBest OA location URL: https://www.nature.com/articles/s41598-022-22179-z.pdfCitation Count: 17
- Sex and Race Reporting and Representation in Noncancerous Voice Clinical Trials: A Meta-Analysis of National Institutes of Health–Registered Research Between 1988 and 20212022RESTRICTEDTitle: Sex and Race Reporting and Representation in Noncancerous Voice Clinical Trials: A Meta-Analysis of National Institutes of Health–Registered Research Between 1988 and 2021Journal Name: Journal of Speech, Language, and Hearing ResearchPublisher: American Speech Language Hearing AssociationVol: 65Issue #: 7Start Page: 2594End Page: 2607Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1044/2022_jslhr-22-00141Citation Count: 6
- Prodromal Parkinson disease — time is brain2021RESTRICTEDTitle: Prodromal Parkinson disease — time is brainJournal Name: Nature Reviews NeurologyPublisher: Springer Science and Business Media LLCVol: 17Issue #: 6Start Page: 329End Page: 330Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41582-021-00489-6Citation Count: 1
-
OPENTitle: Elucidating the importance and regulation of key enhancers for human MEIS1 expressionJournal Name: LeukemiaPublisher: Springer Science and Business Media LLCVol: 36Issue #: 8Start Page: 1980End Page: 1989Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41375-022-01602-4Best OA location URL: https://www.nature.com/articles/s41375-022-01602-4.pdfCitation Count: 3
- From the prodromal stage of multiple sclerosis to disease prevention2022RESTRICTEDTitle: From the prodromal stage of multiple sclerosis to disease preventionJournal Name: Nature Reviews NeurologyPublisher: Springer Science and Business Media LLCVol: 18Issue #: 9Start Page: 559End Page: 572Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41582-022-00686-xCitation Count: 24
-
RESTRICTEDTitle: The potential utility of smell testing to screen for neurodegenerative disordersJournal Name: Expert Review of Molecular DiagnosticsPublisher: Informa UK LimitedVol: 22Issue #: 2Start Page: 139End Page: 148Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/14737159.2022.2037424Best OA location URL: https://qmro.qmul.ac.uk/xmlui/handle/123456789/76598Citation Count: 1
- Investigational therapeutics for the treatment of progressive supranuclear palsy2022RESTRICTEDTitle: Investigational therapeutics for the treatment of progressive supranuclear palsyJournal Name: Expert Opinion on Investigational DrugsPublisher: Informa UK LimitedVol: 31Issue #: 8Start Page: 813End Page: 823Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/13543784.2022.2087179Citation Count: 1
-
RESTRICTEDTitle: Can noninvasive brain stimulation enhance cognition in neuropsychiatric disorders?Journal Name: NeuropharmacologyPublisher: Elsevier BVVol: 64Issue #:Start Page: 566End Page: 578Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2012.06.020Best OA location URL: https://europepmc.org/articles/pmc3725288?pdf=renderCitation Count: 206
- Pharmacological interventions for psychosis in Parkinson’s disease patients2018RESTRICTEDTitle: Pharmacological interventions for psychosis in Parkinson’s disease patientsJournal Name: Expert Opinion on PharmacotherapyPublisher: Informa UK LimitedVol: 19Issue #: 5Start Page: 499End Page: 505Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/14656566.2018.1445721Citation Count: 27